FDA Issues Warning Letters About Claims Regarding Lipodissolve

被引：0

|

作者：

不详

机构：

来源：

JOURNAL OF DRUGS IN DERMATOLOGY | 2010年 / 9卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：874 / 874

页数：1

相关论文

共 50 条

[1] FDA issues warning letters about unapproved eye disorder therapies
[J]. Reactions Weekly, 2023, 1975 (1) : 6 - 6
[2] FDA issues new clinical research warning letters
不详
[J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2002, 50 (05) : 344 - 345
[3] FDA Issues Warning About 'Gas Station Heroin'
Roush, Karen
[J]. AMERICAN JOURNAL OF NURSING, 2024, 124 (05) : 13 - 13
[4] FDA issues warning about 'new' tamoxifen risk
Twombly, R
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (15) : 1122 - 1122
[5] FDA sends 23 warning letters about drug ads
Dorey, E
[J]. CHEMISTRY & INDUSTRY, 2005, (03) : 6 - 6
[6] FDA issues warning on domperidone
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2004, 82 (24) : 25 - 25
[7] FDA issues warning letter
不详
[J]. FOOD TECHNOLOGY, 2007, 61 (06) : 12 - 13
[8] FDA issues ephedrine warning
不详
[J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1996, 96 (06) : 557 - 557
[9] Study examines FDA warning letters about medical devices from 2009
Yang, Hongli
Hyman, William A.
[J]. Biomedical Instrumentation and Technology, 2010, 44 (04): : 336 - 338
[10] AN UPDATED REVIEW OF FDA WARNING AND UNTITLED LETTERS FOR CLINICAL OUTCOME ASSESSMENT CLAIMS BETWEEN 2013 AND 2020
Sams, L.
Slagle, A.
Symonds, T.
Antonova, J.
[J]. VALUE IN HEALTH, 2022, 25 (07) : S468 - S468

← 1 2 3 4 5 →